P. Gaszner

1.0k total citations
30 papers, 803 citations indexed

About

P. Gaszner is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, P. Gaszner has authored 30 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 7 papers in Clinical Psychology. Recurrent topics in P. Gaszner's work include Treatment of Major Depression (7 papers), Child and Adolescent Psychosocial and Emotional Development (6 papers) and Schizophrenia research and treatment (6 papers). P. Gaszner is often cited by papers focused on Treatment of Major Depression (7 papers), Child and Adolescent Psychosocial and Emotional Development (6 papers) and Schizophrenia research and treatment (6 papers). P. Gaszner collaborates with scholars based in Hungary, Sweden and Netherlands. P. Gaszner's co-authors include C. M. Bradshaw, E. Szabadi, Martin Eisemann, Jan van der Ende, Willem A. Arrindell, Ezio Sanavio, Monika Peter, Claudio Sica, Chryse Hatzichristou and János Kállai and has published in prestigious journals such as The British Journal of Psychiatry, Personality and Individual Differences and Journal of Affective Disorders.

In The Last Decade

P. Gaszner

27 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Gaszner Hungary 14 360 196 182 149 132 30 803
Mark H. Townsend United States 16 311 0.9× 230 1.2× 190 1.0× 84 0.6× 181 1.4× 40 1.1k
Outi Poutanen Finland 15 323 0.9× 252 1.3× 144 0.8× 173 1.2× 154 1.2× 27 798
Galina P. Kirillova United States 18 593 1.6× 123 0.6× 174 1.0× 216 1.4× 165 1.3× 28 1.4k
Seyed Mohammad Assadi Iran 14 278 0.8× 123 0.6× 113 0.6× 69 0.5× 68 0.5× 18 779
Jan Campbell United States 20 366 1.0× 258 1.3× 122 0.7× 149 1.0× 80 0.6× 35 1.1k
D. Tedeschi Italy 17 364 1.0× 326 1.7× 72 0.4× 119 0.8× 163 1.2× 35 984
Maximus Berger Australia 17 316 0.9× 238 1.2× 110 0.6× 137 0.9× 88 0.7× 46 1.1k
Michelle L. Van Etten United States 12 692 1.9× 98 0.5× 123 0.7× 210 1.4× 154 1.2× 14 1.3k
Chad D. Emrick United States 15 415 1.2× 170 0.9× 140 0.8× 96 0.6× 70 0.5× 25 1.3k
Francisca López-Torrecillas Spain 16 264 0.7× 245 1.3× 110 0.6× 179 1.2× 144 1.1× 53 1.0k

Countries citing papers authored by P. Gaszner

Since Specialization
Citations

This map shows the geographic impact of P. Gaszner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gaszner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gaszner more than expected).

Fields of papers citing papers by P. Gaszner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gaszner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gaszner. The network helps show where P. Gaszner may publish in the future.

Co-authorship network of co-authors of P. Gaszner

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gaszner. A scholar is included among the top collaborators of P. Gaszner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gaszner. P. Gaszner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halbreich, Uriel, Renato D. Alarcón, Helena Maria Calil, et al.. (2006). Culturally-sensitive complaints of depressions and anxieties in women. Journal of Affective Disorders. 102(1-3). 159–176. 74 indexed citations
2.
Gaszner, P. & Ildikó Miklya. (2005). Major depression and the synthetic enhancer substances, (−)-deprenyl and R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(1). 5–14. 11 indexed citations
3.
Gaszner, P.. (2005). About the menopausal depression.. PubMed. 7(4). 208–14.
4.
Gaszner, P. & Ildikó Miklya. (2004). The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.. PubMed. 6(4). 210–20. 2 indexed citations
5.
Gaszner, P., et al.. (2004). Clozapine maintenance therapy in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(3). 465–469. 24 indexed citations
6.
Bitter, István, et al.. (2003). Prescribing for Inpatients with Schizophrenia: An International Multi-Center Comparative Study. Pharmacopsychiatry. 36(4). 143–149. 42 indexed citations
7.
Gaszner, P., et al.. (2002). Agranulocytosis during clozapine therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(3). 603–607. 13 indexed citations
8.
Boor, Kathryn J., Zsolt Rónai, Zsófia Nemoda, et al.. (2002). Noninvasive Genotyping of Dopamine Receptor D4 (DRD4) UsingNanograms of DNA From Substance-Dependent Patients. Current Medicinal Chemistry. 9(8). 793–797. 37 indexed citations
9.
Gaszner, P.. (2000). Clozapine treatment of different psychoses. European Neuropsychopharmacology. 10. 285–285. 1 indexed citations
10.
Versiani, Márcio, et al.. (1999). Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 60(6). 400–406. 66 indexed citations
11.
Ban, T. A., P. Gaszner, Eugenio Aguglia, et al.. (1998). Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations. Human Psychopharmacology Clinical and Experimental. 13(S1). S29–S39. 50 indexed citations
12.
Gaszner, P.. (1996). Pharmacological treatment of mania (The use of code-HD). European Neuropsychopharmacology. 6. 9–9. 1 indexed citations
13.
Treuer, Tamás, et al.. (1992). IS THE AGRANULOCYTOSIS A PROBLEM IN CLOZAPINE THERAPY?. Clinical Neuropharmacology. 15. 371B–371B. 1 indexed citations
14.
Gaszner, P., C. Perris, Martin Eisemann, & H. Perris. (1988). The early family situation of Hungarian depressed patients.. Acta Psychiatrica Scandinavica. 78(S344). 111–114. 6 indexed citations
15.
Perris, C., et al.. (1987). Depressive Symptomatology at Admission in Hungarian and Swedish Depressed Patients. Psychopathology. 20(1). 1–7. 3 indexed citations
16.
Szabadi, E., P. Gaszner, & C. M. Bradshaw. (1981). Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo. European Journal of Clinical Pharmacology. 19(6). 403–408. 9 indexed citations
17.
Gaszner, P., E. Szabadi, & C. M. Bradshaw. (1980). Comparison of the effects of desipramine and amitriptyline on pupillary responses to noradrenaline and methoxamine in healthy volunteers [proceedings]. British Journal of Clinical Pharmacology. 9(3). 307P–309P. 5 indexed citations
18.
Szabadi, E., C. M. Bradshaw, & P. Gaszner. (1980). The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers. Psychopharmacology. 68(2). 125–134. 24 indexed citations
19.
Szabadi, E., P. Gaszner, & C. M. Bradshaw. (1980). The Peripheral Anticholinergic Activity of Tricyclic Antidepressants: Comparison of Amitriptyline and Desipramine in Human Volunteers. The British Journal of Psychiatry. 137(5). 433–439. 61 indexed citations
20.
Gaszner, P.. (1969). Durch elektrischen Strom verursachte histopathologische Ver�nderungen des Nervensystems. European Archives of Psychiatry and Clinical Neuroscience. 212(3). 309–320. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark H. Townsend Breakdown of academic impact, for papers by Outi Poutanen Breakdown of academic impact, for papers by Galina P. Kirillova Breakdown of academic impact, for papers by Seyed Mohammad Assadi Breakdown of academic impact, for papers by Jan Campbell Breakdown of academic impact, for papers by D. Tedeschi Breakdown of academic impact, for papers by Maximus Berger Breakdown of academic impact, for papers by Michelle L. Van Etten Breakdown of academic impact, for papers by Chad D. Emrick Breakdown of academic impact, for papers by Francisca López-Torrecillas
Rankless by CCL
2026